- One Stent
- Two Stent
Bifurcation Lesions Market was valued at USD 2,257.5 million in 2023 and is poised to grow at a 5.3% CAGR from 2024 to 2030. A bifurcation lesion refers to constriction of the coronary artery near the origin of a significant side branch. It is caused by the turbulent flow of blood and high shear stress and is also more likely to develop atherosclerotic plaque. It is treated using various techniques such as analysis, X-ray exposure, procedure time, and long-term follow-up. The multi-slice computed tomography and three-dimensional angiography are used in the measurement of bifurcation angles. The availability of treatments specifically designed to treat lesions near coronary bifurcation, along with increasing awareness about the treatment procedures, and an increase in percutaneous coronary intervention operations is expected to drive the growth of the bifurcation lesions market over the forecast period.
In addition, the increasing number of geriatric patients and the growing demand for minimally invasive procedures are expected to boost the growth of the bifurcation lesions market. Furthermore, increasing investments in research and development along with the growing medical tourism is expected to further propel the growth of the bifurcation lesions market over the forecast period. For instance, according to a research study, coronary bifurcation lesions procedure comprises about 20% of total percutaneous coronary interventions. In addition, ongoing clinical trials on stents and balloons for the bifurcation lesions treatment also positively impact the market growth. However, factors like high treatment costs and reimbursement issues related to bifurcation lesions are expected to hinder the growth of the bifurcation lesions market over the forecast period. Moreover, the increasing incidence of cardiovascular disease in young age people owing to bad lifestyle choices and increasing endorsement and commercialization of innovative devices for the treatment of bifurcation lesions is expected to provide opportunities for the market players and manufacturers in the growth of the market over the forecast period.
Bifurcation Lesions Market Key Developments:
- In April 2021, Abbott launched the Ultreon 1.0 Software powered by AI , a coronary imaging platform in Europe.
Bifurcation Lesions Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.3%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Bifurcation Lesions Market Dynamics
The bifurcation lesions market is expected to grow over the forecasted period due to the increasing prevalence of coronary diseases across the globe. coronary diseases are more prone to geriatric patients and thus growing geriatric patients across the globe is expected to drive the growth of bifurcation lesions market over the forecast period. In addition, increasing awareness and adoption of advanced coronary stenting techniques and devices are expected to boost the growth of bifurcation lesions market. The advanced coronary stenting techniques and devices are developed to improve the bifurcation lesions treatment outcomes. These include techniques such as culotte, T stenting, DK crush techniques. Thus, increasing investments in research and developments in the treatment of bifurcation lesions are expected to further boost the market growth over the forecast period.
North America Got Highest Share
Bifurcation Lesions Market Regional Analysis
The bifurcation lesions market is segmented based on regions into North America, Asia-pacific, Europe, Latin America, and the Middle East and Africa. The North America bifurcation lesions market is likely to hold a significant revenue share, and in the forecasted years, it is predicted to increase rapidly due to the increasing incidence of coronary artery diseases in this region along with rising investment in the treatment of bifurcation lesions by the market players in this region. Asia Pacific region is expected to have highest CAGR over the forecast period owing to the improvement of healthcare infrastructure and growing medical tourism in countries like India, China, Malaysia in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and startup’s details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Bifurcation Lesions Market Segmentation
By Type
By Application
- Coronary Vascular
- Peripheral Vascular
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The bifurcation lesions market size was valued at USD 2,257.5 million in 2023 and is poised to grow at a 5.3% CAGR from 2024 to 2030
Increasing prevalence of coronary artery disease along with the increasing number of geriatric patients is expected to drive the growth of bifurcation lesions market.
The leading players in the global bifurcation lesions market are Abbott, Boston Scientific Corporation, Cardinal Health, Medtronic, Johnson & Johnson private ltd, Tecomet, C. R. Bard, Inc, Philips Healthcare, Terumo Medical Corporation, Tryton Medical, Inc., Stryker.
High cost of treatment is expected to restrain the growth of bifurcation lesions market over the forecast period.
| 1.Executive Summary |
| 2.Global Bifurcation Lesions Market Introduction |
| 2.1.Global Bifurcation Lesions Market - Taxonomy |
| 2.2.Global Bifurcation Lesions Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Bifurcation Lesions Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Bifurcation Lesions Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Bifurcation Lesions Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. One Stent |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Two Stent |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Bifurcation Lesions Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Coronary Vascular |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Peripheral Vascular |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Bifurcation Lesions Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.One Stent |
| 8.1.2.Two Stent |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Coronary Vascular |
| 8.2.2.Peripheral Vascular |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Bifurcation Lesions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.One Stent |
| 9.1.2.Two Stent |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Coronary Vascular |
| 9.2.2.Peripheral Vascular |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.One Stent |
| 10.1.2.Two Stent |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Coronary Vascular |
| 10.2.2.Peripheral Vascular |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.One Stent |
| 11.1.2.Two Stent |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Coronary Vascular |
| 11.2.2.Peripheral Vascular |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.One Stent |
| 12.1.2.Two Stent |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Coronary Vascular |
| 12.2.2.Peripheral Vascular |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott |
| 13.2.2.Boston Scientific Corporation |
| 13.2.3.Cardinal Health |
| 13.2.4.Medtronic |
| 13.2.5.Johnson & Johnson private ltd |
| 13.2.6.Tecomet |
| 13.2.7.C. R. Bard, Inc |
| 13.2.8.Philips Healthcare |
| 13.2.9.Terumo Medical Corporation |
| 13.2.10.Tryton Medical, Inc. |
| 13.2.11.Stryker |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Abbott
- Boston Scientific Corporation
- Cardinal Health
- Medtronic
- Johnson & Johnson private ltd
- Tecomet
- C. R. Bard, Inc
- Philips Healthcare
- Terumo Medical Corporation
- Tryton Medical, Inc.
- Stryker